Buscador de publicacions

Publicacions

  • Peña C, Alfonso-Ramos M, Arroyo P, Serrano-Blanco A and Aznar I.

    Is epilepsy related to psychiatric disorders in people with intellectual disability? A systematic review.

    Journal of Intellectual Disabilities . : . Nº de cites: 1

    [doi:10.1177/17446295221116506]

  • Sanchez A, Corral C, Gil MM, Peñarrubia-María MT, Gallardo MC, Olmos-Palenzuela MD, Aznar I, Serrano-Blanco A and Rubio-Valera M.

    Effectiveness and cost-effectiveness of an intervention to improve Initial Medication Adherence to treatments for cardiovascular diseases and diabetes in primary care: study protocol for a pragmatic cluster randomised controlled trial and economic model (the IMA-cRCT study).

    bmc primary care . 23(1): 170-170. Nº de cites: 6

    [doi:10.1186/s12875-022-01727-6]

  • Domènech J, SANDRA DÍAZ COFINÉ, Rubio-Valera M and Aznar I.

    Evaluación pre-post de un programa intergeneracional para mejorar el bienestar en personas mayores y los estereotipos edadistas en alumnos de primaria y secundaria: proyecto CRENCO.

    Revista espanola de geriatria y gerontologia . 57(3): 161-167.

    [doi:10.1016/j.regg.2022.04.005]

  • Talens A, López-Pintor E, Bejerano M, Guilabert M, Aznar MT, Aznar I and Lumbreras B.

    Influence of the COVID-19 Pandemic on Adherence to Orally Administered Antineoplastics

    Journal of Clinical Medicine . 11(9): .

    [doi:10.3390/jcm11092436]

  • Carbonell-Duacastella C, Rubio-Valera M, Marqués-Ercilla S, Peñarrubia-María MT, Gil MM, Garcia-Cardenas V, Pasarín MI, Parody-Rúa E and Aznar I.

    Pediatric Medication Noninitiation in Spain.

    Pediatrics . 149(1): .

    [doi:10.1542/peds.2020-034371]

  • Peñarrubia-María MT, Gil MM, Gallardo MC, Aznar I, Serrano-Blanco A, Mendive JM, Garcia-Cardenas, Victoria, Sanchez A and Rubio-Valera M.

    Non-initiation of prescribed medication from a Spanish health professionals' perspective: A qualitative exploration based on Grounded Theory.

    HEALTH & SOCIAL CARE IN THE COMMUNITY . 30(1): 213-221. Nº de cites: 4

    [doi:10.1111/hsc.13431]

  • Zabaleta-Del-Olmo E, Casajuana-Closas M, López-Jiménez T, Pombo H, Pons-Vigués M, Pujol-Ribera E, Cabezas-Peña C, Llobera J, Martí-Lluch R, Vicens C, Motrico E, Gómez-Gómez I, Maderuelo-Fernández JÁ, Recio-Rodriguez JI, Masluk B, Contreras-Martos S, Jacques-Aviñó C, Aznar I, Gil MM, Clavería A, Magallón-Botaya R, Bellón JÁ, Ramos R, Sanchez-Perez A, Moreno-Peral P, Leiva A, González-Formoso C and Bolíbar B.

    Multiple health behaviour change primary care intervention for smoking cessation, physical activity and healthy diet in adults 45 to 75 years old (EIRA study): a hybrid effectiveness-implementation cluster randomised trial.

    BMC Public Health . 21(1): 2208-2208. Nº de cites: 13

    [doi:10.1186/s12889-021-11982-4]

  • Domènech J, Mundó J, Switsers L, van Tilburg T, Fernández D and Aznar I.

    Social network size, loneliness, physical functioning and depressive symptoms among older adults: Examining reciprocal associations in four waves of the Longitudinal Aging Study Amsterdam (LASA)

    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY . 36(10): 1541-1549. Nº de cites: 49

    [doi:10.1002/gps.5560]

  • Aznar I, Zabaleta-Del-Olmo E, Casajuana-Closas M, Sanchez A, Parody-Rúa E, Bolíbar B, Iracheta M, Bulilete O, López-Jiménez T, Pombo-Ramos H, Martín Miguel MV, Magallón-Botaya R, Maderuelo-Fernández JÁ, Motrico E, Bellón J, Martí-Lluch R, Rubio-Valera M and Serrano-Blanco A.

    Cost-effectiveness analysis of a multiple health behaviour change intervention in people aged between 45 and 75 years: a cluster randomized controlled trial in primary care (EIRA study)

    INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY . 18(1): 88-88. Nº de cites: 5

    [doi:10.1186/s12966-021-01144-5]

  • Rubio-Valera M, Marqués-Ercilla S, Peñarrubia-María MT, Urbanos-Garrido RM, Borrell C, Bosch J, Sanchez A and Aznar I.

    Who Suffers From Pharmaceutical Poverty and What Are Their Needs? Evidence From a Spanish Region.

    FRONTIERS IN PHARMACOLOGY . 12: 617687-617687.

    [doi:10.3389/fphar.2021.617687]